Stage-resolved single-cell profiling identifies GASK1B as an interceptive target for doxorubicin cardiotoxicity

20 June 2026 (10:45 - 11:00)
Organised by: Logo
Congress Presentation Part of: Young Investigator Award - Basic and Translational Research Research and New Technology Delegates Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology